While GST on Tocilizumab and Amphotericin B is slashed to nil from 5 per cent, the rate on Remdesivir and Heparin is lowered from 12 per cent to 5 per cent.
Drug firm Roche India, which supplies tocilizumab in India, had told the court it can only endeavour to supply the Covid drug but can't assure to meet the market demand.
States like Delhi, Maharashtra, Chandigarh, Kerala and Chhattisgarh have complained of acute shortage of tocilizumab. The drug is used to treat Covid and rheumatoid arthritis.
While the commission didn’t mention provisions under which IndiGo's market domination would be examined, Competition Act 2002 prohibits abuse of dominant position by any enterprise.
It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS